keyword
https://read.qxmd.com/read/38650613/plain-language-summary-of-the-vaccination-of-poultry-against-highly-pathogenic-avian-influenza-part-2-surveillance-and-mitigation-measures
#1
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2024: EFSA journal
https://read.qxmd.com/read/38650612/re-evaluation-of-certain-aspects-of-the-efsa-scientific-opinion-of-april-2010-on-risk-assessment-of-parasites-in-fishery-products-based-on-new-scientific-data-part-1-tors1-3
#2
JOURNAL ARTICLE
Konstantinos Koutsoumanis, Ana Allende, Avelino Alvarez-Ordóñez, Sara Bover-Cid, Marianne Chemaly, Alessandra De Cesare, Lieve Herman, Friederike Hilbert, Roland Lindqvist, Maarten Nauta, Romolo Nonno, Luisa Peixe, Giuseppe Ru, Marion Simmons, Panagiotis Skandamis, Elisabetta Suffredini, Kurt Buchmann, Mercedes Careche, Arne Levsen, Simonetta Mattiucci, Ivona Mladineo, Maria João Santos, Rubén Barcia-Cruz, Alesandro Broglia, Kateryna Chuzhakina, Sonagnon Martin Goudjihounde, Beatriz Guerra, Winy Messens, Irene Muñoz Guajardo, Declan Bolton
Surveillance data published since 2010, although limited, showed that there is no evidence of zoonotic parasite infection in market quality Atlantic salmon, marine rainbow trout, gilthead seabream, turbot, meagre, Atlantic halibut, common carp and European catfish. No studies were found for greater amberjack, brown trout, African catfish, European eel and pikeperch. Anisakis pegreffii , A. simplex (s. s.) and Cryptocotyle lingua were found in European seabass, Atlantic bluefin tuna and/or cod, and Pseudamphistomum truncatum and Paracoenogonimus ovatus in tench, produced in open offshore cages or flow-through ponds or tanks...
April 2024: EFSA journal
https://read.qxmd.com/read/38648254/development-of-a-non-infectious-control-for-viral-hemorrhagic-fever-pcr-assays
#3
JOURNAL ARTICLE
Matthew A Knox, Collette Bromhead, David Ts Hayman
Assay validation is an essential component of disease surveillance testing, but can be problematic in settings where access to positive control material is limited and a safety risk for handlers. Here we describe a single non-infectious synthetic control that can help develop and validate the PCR based detection of the viral causes of Crimean-Congo hemorrhagic fever, Ebola virus disease, Lassa fever, Marburg virus disease and Rift Valley fever. We designed non-infectious synthetic DNA oligonucleotide sequences incorporating primer binding sites suitable for five assays, and a T7 promotor site which was used to transcribe the sequence...
April 22, 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38647241/jynneos-vaccine-safety-surveillance-during-the-2022-mpox-outbreak-using-the-vaccine-adverse-event-reporting-system-vaers-and-v-safe-united-states-2022-2023
#4
JOURNAL ARTICLE
Jonathan Duffy, Tanya R Myers, Paige Marquez, Douglas Rouse, Hannah Brown, Bicheng Zhang, David K Shay, Pedro L Moro
BACKGROUND: In response to the 2022 mpox outbreak in the United States, people with higher potential for exposure to mpox were recommended to receive two doses of the JYNNEOS vaccine. Vaccine safety was monitored using two complementary systems. METHODS: The Vaccine Adverse Event Reporting System (VAERS) is a passive surveillance system that accepts reports of adverse events following vaccination. VAERS is capable of rapidly identifying rare adverse events and unusual reporting patterns...
April 19, 2024: Sexually Transmitted Diseases
https://read.qxmd.com/read/38646719/efficacy-and-safety-of-bimekizumab-in-the-treatment-of-psoriatic-arthritis-a-systematic-review-and-meta-analysis
#5
REVIEW
Qin-Yi Su, Liu Yang, Ting-Yu Cao, Hai-Ying Dang, Zhuo-Chen Han, Jia-Jing Cao, He-Yi Zhang, Ting Cheng, Sheng-Xiao Zhang, Yue-Hong Huo
BACKGROUND: Bimekizumab, a humanized monoclonal IgG1 antibody targeting both interleukin (IL)-17A and IL-17F, could be effective for treating Psoriatic arthritis (PsA). This study aimed to systematically evaluate the efficacy and safety of bimekizumab in the management of PsA. RESEARCH DESIGN AND METHODS: A comprehensive literature search by August 2023 was performed through PubMed, Embase, Cochrane Controlled Register of Trials, and ClinicalTrials.gov. investigating the efficacy or safety data of bimekizumab in the treatment of PsA...
April 22, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38643356/safety-and-effectiveness-of-clofarabine-in-japanese-patients-with-relapsed-refractory-acute-lymphoblastic-leukaemia-a-post-marketing-surveillance-study
#6
JOURNAL ARTICLE
Hirotaka Kazama, Satoshi Nishina, Takeshi Seto
OBJECTIVE: Clofarabine is used to treat acute lymphoblastic leukaemia, but evidence of its safety and effectiveness in Japanese patients is limited. We evaluated the safety and effectiveness of clofarabine in patients with relapsed/refractory acute lymphoblastic leukaemia in real-world clinical practice in Japan. METHODS: An observational, multicenter, post-marketing, all-case surveillance was conducted for safety. Effectiveness analyses were conducted in patients aged ≤21 years and those treated with clofarabine monotherapy and combination therapy (clofarabine plus etoposide and cyclophosphamide)...
April 20, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38642847/navigating-the-landscape-of-medical-device-advisories-a-special-report-from-the-canadian-heart-rhythm-society-device-advisory-committee
#7
JOURNAL ARTICLE
Jason G Andrade, Alice Virani, Amelia Staunton, Marc Bains, Derek S Chew, Nathaniel M Hawkins, Jacqueline Joza, Clarence Khoo, Jaimie Manlucu, Francois Philippon, Calum Redpath, Laurence Sterns
Cardiac implantable electronic devices (CIED) are often important for regulating cardiac rate and rhythm. Pacemakers and defibrillators are among the top 10 most-implanted medical devices, with >1.5 million devices implanted annually. While millions of patients have benefited with improved quality of life and survival, CIED-systems are increasingly complex and do not always perform according to expectations. Advisory notices communicate important information about the safety and performance of a medical device to healthcare providers and patients...
April 18, 2024: Canadian Journal of Cardiology
https://read.qxmd.com/read/38641999/incidence-and-risk-factors-for-potential-drug-drug-interactions-in-outpatients-receiving-opioid-analgesics
#8
JOURNAL ARTICLE
Fei Chu, Yang Yao, Bei Gao, Mingzhi Huang, Lingti Kong
BACKGROUND: Opioids are the most frequently used drugs to treat pain in cancer patients. However opioid analgesics can cause adverse effects and potential drug-drug interaction. RESEARCH DESIGN AND METHODS: This cross-sectional retrospective study analyzed pDDI in 1839 patients with opioid analgesics in a large comprehensive hospital in China from January 1 to 31 December 2022. Three drug interaction databases were used to screen for pDDI including Drugs (U.S.A...
April 20, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38639672/challenges-and-opportunities-for-access-to-advanced-therapy-medicinal-products-in-brazil
#9
JOURNAL ARTICLE
Camile Giaretta Sachetti, Augusto Barbosa, Antonio Carlos Campos de Carvalho, Denizar Vianna Araujo, Everton Nunes da Silva
BACKGROUND AIMS: The marketing authorization of Advanced Therapy Medicinal Products (ATMPs) in Brazil is recent. The features of these therapies impose specialized regulatory action and are consequently challenging for developers. The goal of this study was to identify the industry's experience in clinical development, marketing authorization and access to ATMPs through the Unified Health System (SUS, acronym in Portuguese), from a regulatory perspective. METHODS: A survey containing structured questions was conducted among research participants who work at companies that commercialize ATMPs...
March 29, 2024: Cytotherapy
https://read.qxmd.com/read/38639136/device-regulation-and-surveillance-in-vascular-care-challenges-and-opportunities
#10
REVIEW
Alyssa J Pyun, Philip P Goodney, Jens Eldrup-Jorgensen, James Wadzinski, Eric A Secemsky, Joaquin E Cigarroa
Cardiovascular devices are essential for the treatment of cardiovascular diseases including cerebrovascular, coronary, valvular, congenital, peripheral vascular and arrhythmic diseases. The regulation and surveillance of vascular devices in real-world practice, however, presents challenges during each individual product's life cycle. Four examples illustrate recent challenges and questions regarding safety, appropriate use and efficacy arising from FDA approved devices used in real-world practice. We outline potential pathways wherein providers, regulators and payors could potentially provide high-quality cardiovascular care, identify safety signals, ensure equitable device access, and study potential issues with devices in real-world practice...
April 19, 2024: Catheterization and Cardiovascular Interventions
https://read.qxmd.com/read/38638555/vaccination-of-poultry-against-highly-pathogenic-avian-influenza-part-2-surveillance-and-mitigation-measures
#11
JOURNAL ARTICLE
Søren Saxmose Nielsen, Julio Alvarez, Dominique Joseph Bicout, Paolo Calistri, Elisabetta Canali, Julian Ashley Drewe, Bruno Garin-Bastuji, Christian Gortázar, Mette S Herskin, Virginie Michel, Miguel Ángel Miranda Chueca, Barbara Padalino, Helen Clare Roberts, Hans Spoolder, Karl Stahl, Antonio Velarde, Arvo Viltrop, Christoph Winckler, Alessio Bortolami, Claire Guinat, Timm Harder, Arjan Stegeman, Calogero Terregino, Barbara Lanfranchi, Ludovica Preite, Inma Aznar, Alessandro Broglia, Francesca Baldinelli, Jose Luis Gonzales Rojas
Selecting appropriate diagnostic methods that take account of the type of vaccine used is important when implementing a vaccination programme against highly pathogenic avian influenza (HPAI). If vaccination is effective, a decreased viral load is expected in the samples used for diagnosis, making molecular methods with high sensitivity the best choice. Although serological methods can be reasonably sensitive, they may produce results that are difficult to interpret. In addition to routine molecular monitoring, it is recommended to conduct viral isolation, genetic sequencing and phenotypic characterisation of any HPAI virus detected in vaccinated flocks to detect escape mutants early...
April 2024: EFSA journal
https://read.qxmd.com/read/38638541/a-canadian-paediatric-surveillance-program-study-to-guide-safe-integration-of-virtual-care-for-children
#12
JOURNAL ARTICLE
Shelley Vanderhout, Daniel Rosenfield, Ellen B Goldbloom
No abstract text is available yet for this article.
December 2023: Paediatrics & Child Health
https://read.qxmd.com/read/38635813/wastewater-based-epidemiology-as-a-surveillance-tool-during-the-current-covid-19-pandemic-on-a-college-campus-east-carolina-university-and-its-accuracy-in-predicting-sars-cov-2-outbreaks-in-dormitories
#13
JOURNAL ARTICLE
Avian White, Guy Iverson, LaNika Wright, John T Fallon, Kimberly P Briley, Changhong Yin, Weihua Huang, Charles Humphrey
The COVID-19 outbreak led governmental officials to close many businesses and schools, including colleges and universities. Thus, the ability to resume normal campus operation required adoption of safety measures to monitor and respond to COVID-19. The objective of this study was to determine the efficacy of wastewater-based epidemiology as a surveillance method in monitoring COVID-19 on a college campus. The use of wastewater monitoring as part of a surveillance program to control COVID-19 outbreaks at East Carolina University was evaluated...
2024: PloS One
https://read.qxmd.com/read/38635655/the-omop-common-data-model-in-australian-primary-care-data-building-a-quality-research-ready-harmonised-dataset
#14
JOURNAL ARTICLE
Roger Ward, Christine Mary Hallinan, David Ormiston-Smith, Christine Chidgey, Dougie Boyle
BACKGROUND: The use of routinely collected health data for secondary research purposes is increasingly recognised as a methodology that advances medical research, improves patient outcomes, and guides policy. This secondary data, as found in electronic medical records (EMRs), can be optimised through conversion into a uniform data structure to enable analysis alongside other comparable health metric datasets. This can be achieved with the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM), which employs a standardised vocabulary to facilitate systematic analysis across various observational databases...
2024: PloS One
https://read.qxmd.com/read/38635474/covid-19-vaccination-coverage-and-rates-of-sars-cov-2-infection-and-covid-19-associated-hospitalization-among-residents-in-nursing-homes-national-healthcare-safety-network-united-states-october-2023-february-2024
#15
JOURNAL ARTICLE
David Franklin, Kira Barbre, Theresa A Rowe, Hannah E Reses, Jason Massey, Lu Meng, Philip Dollard, Heather Dubendris, Molly Stillions, Lindsay Robinson, Jacques W Clerville, Kara Jacobs Slifka, Andrea Benin, Jeneita M Bell
Nursing home residents are at increased risk for developing severe COVID-19. Nursing homes report weekly facility-level data on SARS-CoV-2 infections, COVID-19-associated hospitalizations, and COVID-19 vaccination coverage among residents to CDC's National Healthcare Safety Network. This analysis describes rates of incident SARS-CoV-2 infection, rates of incident COVID-19-associated hospitalization, and COVID-19 vaccination coverage during October 16, 2023-February 11, 2024. Weekly rates of SARS-CoV-2 infection ranged from 61...
April 18, 2024: MMWR. Morbidity and Mortality Weekly Report
https://read.qxmd.com/read/38633371/assessing-the-health-impact-of-disinfection-byproducts-in-drinking-water
#16
JOURNAL ARTICLE
Indrajit Kalita, Andreas Kamilaris, Paul Havinga, Igor Reva
This study provides a comprehensive investigation of the impact of disinfection byproducts (DBPs) on human health, with a particular focus on DBPs present in chlorinated drinking water, concentrating on three primary DBP categories (aliphatic, alicyclic, and aromatic). Additionally, it explores pivotal factors influencing DBP formation, encompassing disinfectant types, water source characteristics, and environmental conditions, such as the presence of natural materials in water. The main objective is to discern the most hazardous DBPs, considering criteria such as regulation standards, potential health impacts, and chemical diversity...
April 12, 2024: ACS ES&T water
https://read.qxmd.com/read/38631952/overview-of-u-s-covid-19-vaccine-safety-surveillance-systems
#17
JOURNAL ARTICLE
Julianne Gee, Tom T Shimabukuro, John R Su, David Shay, Margaret Ryan, Sridhar V Basavaraju, Karen R Broder, Matthew Clark, C Buddy Creech, Francesca Cunningham, Kristin Goddard, Harrison Guy, Kathryn M Edwards, Richard Forshee, Tanya Hamburger, Anne M Hause, Nicola P Klein, Ian Kracalik, Chris Lamer, David A Loran, Michael M McNeil, Jay Montgomery, Pedro Moro, Tanya R Myers, Christine Olson, Matthew E Oster, Andrea J Sharma, Ryan Schupbach, Eric Weintraub, Brett Whitehead, Steven Anderson
The U.S. COVID-19 vaccination program, which commenced in December 2020, has been instrumental in preventing morbidity and mortality from COVID-19 disease. Safety monitoring has been an essential component of the program. The federal government undertook a comprehensive and coordinated approach to implement complementary safety monitoring systems and to communicate findings in a timely and transparent way to healthcare providers, policymakers, and the public. Monitoring involved both well-established and newly developed systems that relied on both spontaneous (passive) and active surveillance methods...
April 16, 2024: Vaccine
https://read.qxmd.com/read/38630680/a-simulation-based-comparison-of-drug-drug-interaction-signal-detection-methods
#18
REVIEW
Dagyeom Jung, Inkyung Jung
Several statistical methods have been proposed to detect adverse drug reactions induced by taking two drugs together. These suspected adverse drug reactions can be discovered through post-market drug safety surveillance, which mainly relies on spontaneous reporting system database. Most previous studies have applied statistical models to real world data, but it is not clear which method outperforms the others. We aimed to assess the performance of various detection methods by implementing simulations under various conditions...
2024: PloS One
https://read.qxmd.com/read/38629617/mycotoxins-and-pyrrolizidine-alkaloids-in-herbal-dietary-supplements
#19
JOURNAL ARTICLE
Zane Berzina, Romans Pavlenko, Elena Bartkiene, Vadims Bartkevics
The market demand for herbal dietary supplements is rapidly growing and such products are becoming more common and accessible to consumers. However, the knowledge about their safety remains incomplete. Herbal dietary supplements are one of the food groups that can contribute significantly to human health concerns arising from chronic exposure to pyrrolizidine alkaloids and mycotoxins. This study aimed to simultaneously determine 79 natural contaminants, including mycotoxins, as well as pyrrolizidine and tropane alkaloids in herbal dietary supplements in one analytical run...
April 17, 2024: Food Additives & Contaminants. Part B, Surveillance
https://read.qxmd.com/read/38629402/immune-checkpoint-inhibitor-related-myositis-an-observational-retrospective-pharmacovigilance-study
#20
JOURNAL ARTICLE
Hezhe Lu, Hui Yang, Zhexin Ding, Zhuoling An, Yong Zhao
BACKGROUND: Immune checkpoint inhibitors (ICIs) hold promise as treatment options for various types of cancer. However, recent case reports have brought attention to myositis, a potentially life-threatening complication associated with ICIs. This study aims to assess the spectrum of myositis associated with ICIs, including its clinical features, risk factors for fatal cases, adverse events (AEs) accompanying ICIs-related myositis, and the risk of myositis in different populations in real-world settings...
April 17, 2024: Expert Opinion on Drug Safety
keyword
keyword
87441
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.